Ignite Creation Date:
2024-05-05 @ 11:11 PM
Last Modification Date:
2024-10-26 @ 10:30 AM
Study NCT ID:
NCT01275222
Status:
COMPLETED
Last Update Posted:
2021-06-25
First Post:
2011-01-10
Brief Title:
Everolimus in Combination With Imatinib in Patients With Glivec RefractoryResistant Gastrointestinal Stromal Tumors
Sponsor:
Organization:
Novartis